FDA Adverse Event Injury Summary report: N

CAGE 10X18X55-10DEG

MDR report key: 17622966 · Received August 24, 2023

Report

Report Number
MW5144932
Event Type
Injury
Date Received
August 24, 2023
Date of Event
August 3, 2023
Report Date
August 19, 2023
Manufacturer
NUVASIVE - NUVA / NUVASIVE, INC.
Product Code
MAX
Adverse Event
Yes
Product Problem
Yes
Report Source
Voluntary report
Reporter Location
NV, US
Reporter Occupation
PATIENT
Health Professional
*

Narratives

Description of Event or Problem · 0

HAD SPINAL SURGERY TO IMPLANT A SPACER ON (B)(6) 2023 TO RELIEVE PRESSURE BETWEEN L3-4. TWO DEVICES IMPLANTED IN SPINE LUMBAR. POST OP BACTERIAL INFECTION DIAGNOSED UPON ADMISSION TO HOSPITAL ON (B)(6) 2023. EXPERIENCED SEVERE PAIN AND SPASMS SINCE SURGERY AND MRI CONDUCTED ON (B)(6) 2023 AND READ ON (B)(6) 2023 FOUND "STATUS POST INTERBODY SPACER AT L3-4 WITH EDEMA IN THE DISC SPACE, ADJACENT VERTEBRAL BODIES, VENTRAL EPIDURAL SPACE AND PSOAS MUSCLE WITH APPARENT LEFT PSOAS ABSCESS. FINDINGS ARE CONCERNING FOR DISCITIS OSTEOMYELITIS." HOSPITALIZED FROM (B)(6) 2023 THROUGH (B)(6) 2023. TREATED WITH BROAD SPECTRUM IV ANTIBIOTICS AND RELEASED WITH PICC LINE INSTALLED TO CONTINUE IV ANTIBIOTICS FOR 6-8 WEEKS. DUE TO LAB ERROR THE BACTERIA WAS NOT SPECIATED AND THERE WAS NO ORIGINAL SPECIMEN LEFT TO DO SO FROM BEFORE ANTIBIOTICS WERE ADMINISTERED IN THE HOSPITAL. TWO DEVICES IMPLANTED: 1. INFUSE BONE GRAFT SMALL- MANUFACTURER: SOFAMOR DANEK- SOFA; MODEL NUMBER: 7510200; LOT NUMBER: MGP7850AAA; 2. CAGE 10X18X55-10DEG- MANUFACTURER: NUVASIVE - NUVA; MODEL NUMBER: 1181055P2. IMPLANTED BY: (B)(6), IMPLANTED AT: (B)(6). "STATUS POST INTERBODY SPACER AT L3-4 WITH EDEMA IN THE DISC SPACE, ADJACENT VERTEBRAL BODIES, VENTRAL EPIDURAL SPACE AND PSOAS MUSCLE WITH APPARENT LEFT PSOAS ABSCESS. FINDINGS ARE CONCERNING FOR DISCITIS OSTEOMYELITIS." REFERENCE REPORT MW5144931.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1434873 CAGE 10X18X55-10DEG INTERVERTEBRAL FUSION DEVICE WITH BONE GRAFT, LUMBAR MAX NUVASIVE - NUVA / NUVASIVE, INC. 1181055P2

Patients

Seq Age Sex Outcome Treatment
1 67 YR Male Required Intervention| H| L